Search:
Login:
OR

Cannabis Blog

Mexico Legalizes Medical Marijuana

Category: Legalization | Posted on Sat, December, 17th 2016 by THCFinder

Medicinal cannabis overwhelming passes in Mexican Senate.

You may remember in our previous post, that Mexico was set to vote on legalizing medicinal marijuana. While there was concern that other issues would take precedence over the marijuana legislation, the Senate was able to come to a decision on the new bill.

In a landslide victory of 98-7, medicinal cannabis was voted to pass. As we previously reported, the focus of this bill was to expand access to CBD. However, this bill, also allows a small percentage (1% or less) of THC to be present in medicinal products.

Read More:https://www.theweedblog.com/mexico-legalizes-medicinal-cannabis/


Comments

After State Legalizes Recreational Pot, Governor Wants to End Medical Marijuana

Category: Medical Marijuana | Posted on Sat, December, 17th 2016 by THCFinder

Governor Paul LePage failed to convince Maine voters that legalizing recreational marijuana would be a “deadly” disaster for the state. So now, the avowed Donald Trump supporter is trying to do away with medical marijuana.

Maine voters on Election Day appeared to narrowly approve Question 1, which legalizes two and a half ounces of cannabis and six mature plants for adults 21 and over. But with the margin of victory less than one percent of the vote, legalization opponents called for a recount.

Results from the recount, already delayed thanks to a lack of volunteers from the opposing side to help count, will now have to wait until 2017, as state election officials paused the process Friday for a two-week winter holiday break.

Read More:http://hightimes.com/news/after-state-legalizes-recreational-pot-governor-wants-to-end-medical-marijuana/


Comments

What strain are you smoking on today?

Category: Fun | Posted on Fri, December, 16th 2016 by THCFinder


Comments

Company Behind CBD-Based Drug Leads Way Despite Trump, Economic Fears

Category: Medical Marijuana | Posted on Fri, December, 16th 2016 by THCFinder

Having expressed understandable apprehension due to recent political events in the U.S. and Britain (i.e. Trump’s election and Brexit), London-based GW Pharmaceuticals announced on Monday that they suffered a 62 percent revenue drop for 2016.

However, things turned around quickly.

GW’s stock jumped 5.5 percent on the first day of the new trading week, right after the company announced positive results for one of its flagship therapies, Epidiolex. This cannabidiol-based drug treats two of the most difficult-to-treat forms of epilepsy, especially in children: Dravet Syndrome and Lennox-Gastaut Syndrome.

“We are making very good progress toward a NDA [UK’s equivalent of the FDA] submission to the FDA, as well as preparations for commercial launch and look forward to the opportunity to make this important new medicine available to patients as quickly as possible,” said Justin Glover, GW’s Chief Executive Officer, on the company’s website.

Read More:http://hightimes.com/medicinal/company-behind-cbd-based-drug-leads-way-despite-trump-economic-fears/


Comments

That 70s Show - Kitty high

Category: Videos | Posted on Fri, December, 16th 2016 by THCFinder


Comments


Search





Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
10 Miles Away | Los Angeles,
10 Miles Away | Los Angeles,
29.5 Miles Away | La Puente, West,
February 22, 2017 | Category: Fun
February 22, 2017 | Category: Celebrities
February 22, 2017 | Category: Videos
Mobile Apps
Copyright 2017 THCFinder.com
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us